Avenue Biosciences

📍 Palo Alto, United States🗓 Founded 2023👥 21 employees💰 Last funded Jan 2026
Biotechnology Research🌐 avenuebiosciences.com
Website LinkedIn
Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities.
6
Total investors
5
Early stage
1
Mid stage
0
Late stage
2023
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
Poland
3
United Kingdom
1
Germany
1
Sweden
1
Investor activity2024–2026 · investors recorded per year
202412025420261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Avenue Biosciences?
Avenue Biosciences has 6 investors on record on gritt.io, including 5 early-stage backers, 1 mid-stage.
When did Avenue Biosciences last raise funding?
The most recent investment in Avenue Biosciences recorded on gritt.io was in January 2026.
When was Avenue Biosciences founded?
Avenue Biosciences was founded in 2023.
What industry is Avenue Biosciences in?
Avenue Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Avenue Biosciences based?
Avenue Biosciences is headquartered in Palo Alto, United States.